A detailed history of Black Rock Inc. transactions in Amicus Therapeutics, Inc. stock. As of the latest transaction made, Black Rock Inc. holds 22,849,449 shares of FOLD stock, worth $227 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
22,849,449
Previous 22,988,139 0.6%
Holding current value
$227 Million
Previous $326 Million 17.48%
% of portfolio
0.01%
Previous 0.01%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 10, 2024

SELL
$11.43 - $14.24 $1.59 Million - $1.97 Million
-138,690 Reduced 0.6%
22,849,449 $269 Million
Q4 2023

Feb 13, 2024

BUY
$9.97 - $14.52 $20.4 Million - $29.7 Million
2,046,362 Added 9.77%
22,988,139 $326 Million
Q3 2023

Nov 13, 2023

BUY
$11.78 - $13.86 $508,707 - $598,530
43,184 Added 0.21%
20,941,777 $255 Million
Q2 2023

Aug 11, 2023

BUY
$10.72 - $13.3 $12.4 Million - $15.4 Million
1,160,568 Added 5.88%
20,898,593 $262 Million
Q1 2023

May 12, 2023

SELL
$10.91 - $13.54 $4.36 Million - $5.42 Million
-400,053 Reduced 1.99%
19,738,025 $219 Million
Q4 2022

Feb 13, 2023

BUY
$9.89 - $12.7 $2.37 Million - $3.04 Million
239,526 Added 1.2%
20,138,078 $246 Million
Q3 2022

Nov 14, 2022

SELL
$9.82 - $12.75 $3.45 Million - $4.48 Million
-351,306 Reduced 1.73%
19,898,552 $208 Million
Q2 2022

Aug 12, 2022

BUY
$6.23 - $11.12 $4.09 Million - $7.3 Million
656,857 Added 3.35%
20,249,858 $217 Million
Q1 2022

May 12, 2022

SELL
$7.89 - $12.48 $1.71 Million - $2.71 Million
-217,347 Reduced 1.1%
19,593,001 $186 Million
Q4 2021

Feb 10, 2022

BUY
$9.82 - $12.44 $2.2 Million - $2.79 Million
224,150 Added 1.14%
19,810,348 $229 Million
Q3 2021

Nov 09, 2021

SELL
$8.74 - $11.84 $6.26 Million - $8.48 Million
-716,072 Reduced 3.53%
19,586,198 $187 Million
Q2 2021

Aug 11, 2021

BUY
$8.71 - $10.72 $177 Million - $218 Million
20,302,270 New
20,302,270 $196 Million

Others Institutions Holding FOLD

About AMICUS THERAPEUTICS, INC.


  • Ticker FOLD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 280,497,984
  • Market Cap $2.78B
  • Description
  • Amicus Therapeutics, Inc., a biotechnology company, focuses on discovering, developing, and delivering medicines for rare diseases. Its commercial product and product candidates include Galafold, an oral precision medicine for the treatment of adults with a confirmed diagnosis of Fabry disease and an amenable galactosidase alpha gene variant bas...
More about FOLD
Track This Portfolio

Track Black Rock Inc. Portfolio

Follow Black Rock Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Black Rock Inc., based on Form 13F filings with the SEC.

News

Stay updated on Black Rock Inc. with notifications on news.